Cadrenal Therapeutics CVKD
NASDAQ CVKD
$1.58 -0.02 (-1.25%)
As of: Aug 21, 2026 · 3:59 PM EDT

Cadrenal Therapeutics (CVKD) EPS (Basic) (2022 - 2026)

Cadrenal Therapeutics (CVKD) posted EPS (Basic) of -$2.48 for Q3 2024, down 10.07% sequentially from -$2.25 in Q2 2024, and down 43.13% YoY from -$4.36 in Q4 2023.

Cadrenal Therapeutics (CVKD) EPS (Basic) (2022 - 2026) Analysis & Trends

Cadrenal Therapeutics has reported EPS (Basic) for 3 years, with the latest figure at -$2.48 in Q3 2024.

  • Quarterly EPS (Basic) fell 43.13% year-over-year to -$2.48 in Q3 2024, while the trailing twelve-month figure through Jun 2025 was -$1.39 (up 78.7% YoY) and the FY2023 annual result came in at -$9.29, up 87.3% from the prior year.
  • EPS (Basic) declined to -$2.48 in Q3 2024 per CVKD's latest filing, from -$2.25 in the prior quarter.
  • Over five years, EPS (Basic) peaked at -$0.35 in Q1 2022 and troughed at -$11.92 in Q4 2022.
  • A 3-year average of -$3.08 and a median of -$1.84 in 2022 frame the typical range for EPS (Basic).
  • The widest YoY moves for EPS (Basic): up 89.33% in 2023, down 1920.35% in 2023.
  • Over 3 years, EPS (Basic) stood at -$11.92 in 2022, then soared by 89.33% to -$1.27 in 2023, then plunged by 94.77% to -$2.48 in 2024.
  • According to Business Quant data, EPS (Basic) over the past three periods registered -$2.48, -$2.25, and -$1.56 for Q3 2024, Q2 2024, and Q1 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 12.62
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 7.59
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -1.96
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 2.12
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 1.23
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -0.72
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -0.06
9 Royalty Pharma 27.27 Bn 26.43 Bn - 0.18
10 Cadrenal Therapeutics 4.59 Mn 2.19 Mn - -1.14

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.14
Jun 30, 2025 -1.87
Sep 30, 2024 -2.48
Jun 30, 2024 -2.25
Mar 31, 2024 -1.56
Dec 31, 2023 -1.27
Sep 30, 2023 -1.73
Jun 30, 2023 -2.56
Mar 31, 2023 -6.97
Dec 31, 2022 -11.92
Sep 30, 2022 -1.84
Jun 30, 2022 -0.95
Mar 31, 2022 -0.35